Abstract
Premature clopidogrel discontinuation is an important cause of stent thrombosis, myocardial infarction, and death after drug-eluting stent (DES) placement. Previous studies of clopidogrel nonadherence after DES placement have had short follow-up and have relied on self-reported adherence. All patients who underwent DES placement from January 2008 to December 2011 at a single safety-net hospital and received medications through the county-subsidized health plan were considered for inclusion; those with
Original language | English (US) |
---|---|
Pages (from-to) | 522-525 |
Number of pages | 4 |
Journal | American Journal of Cardiology |
Volume | 117 |
Issue number | 4 |
DOIs | |
State | Published - Feb 15 2016 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine